Parallel Advisors’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.2K Buy
164
+90
+122% +$2.45K ﹤0.01% 3016
2025
Q4
$2.01K Hold
74
﹤0.01% 3130
2025
Q3
$1.91K Hold
74
﹤0.01% 3058
2025
Q2
$1.51K Sell
74
-859
-92% -$16.7K ﹤0.01% 3112
2025
Q1
$16.9K Buy
933
+854
+1,081% +$19.1K ﹤0.01% 2219
2024
Q4
$2K Buy
79
+57
+259% +$1.55K ﹤0.01% 2970
2024
Q3
$748 Hold
22
﹤0.01% 3096
2024
Q2
$814 Hold
22
﹤0.01% 3008
2024
Q1
$923 Hold
22
﹤0.01% 2951
2023
Q4
$873 Hold
22
﹤0.01% 2967
2023
Q3
$605 Hold
22
﹤0.01% 3071
2023
Q2
$746 Sell
22
-2
-8% -$67 ﹤0.01% 3004
2023
Q1
$864 Hold
24
﹤0.01% 2992
2022
Q4
$1.07K Sell
24
-2
-8% -$71 ﹤0.01% 2881
2022
Q3
$1K Buy
26
+4
+18% +$123 ﹤0.01% 2866
2022
Q2
$1K Buy
+22
New +$639 ﹤0.01% 2722

Other funds holding CLDX